TP53 and breast carcinoma: To check whether the stimulatory effect of MARS2 knockdown on p53 level is not limited to the lung cancer cells, we selected MCF7 human breast cancer cells, which also has a wild-type p53, and conducted western blot analysis of p53 upon MARS2 knockdown.